Instant Report
FDF

Date: 23-Aug-2021

JW Therapeutics Announces Strategic Partnership With MediTrust Health

JW Therapeutics, an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, today announced that it has entered into a strategic partnership with MediTrust Health. Leveraging the respective business advantages, both parties plan to strengthen cooperation in supplementary medical insurance and health insurance policy, to relieve the payment burden of patients and improve the accessibility of CAR-T therapy through private commercial insurance policy.

Meanwhile, both parties jointly held a seminar on “Establishing the Multi-level Medical Security System for CAR-T Therapy”, and conducted in-depth discussions on topics such as how to establish the multi-level private healthcare security system and the innovative payment system.